{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif4m7d3uya3mb3jmpsi7uu3vapgcuhibfh6vdfdpraakv3qp7avhm",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3mmf3stxctdt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidecdosmhubtpgz7w6la4zkdisv5zigdldmueguqjn5to537q3oae"
    },
    "mimeType": "image/jpeg",
    "size": 353003
  },
  "path": "/2026/05/21/science/retatrutide-weight-loss-drug.html",
  "publishedAt": "2026-05-21T10:45:05.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Obesity",
    "Drugs (Pharmaceuticals)",
    "Weight",
    "GLP-1 RAs (Drug)",
    "Hormones",
    "Bariatric Surgery",
    "Clinical Trials",
    "Surgery and Surgeons",
    "Eli Lilly and Company",
    "United States"
  ],
  "textContent": "People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.",
  "title": "Experimental Drug Yields Dramatic Weight Loss"
}